Takeda Pharmaceuticals, Massachusetts' largest biopharma employer, will lay off nearly 250 workers at its 500 Kendall Street location in Cambridge starting in July 2026, with some layoffs extending into 2027. The company announced the cuts through a state filing on March 28, 2026, following board approval of a broader cost-saving plan on March 25. The restructuring aims to generate approximately $1.25 billion in annual savings by 2028 and affects up to 637 total employees, including 387 workers in other states.
Story comments
Loading comments…